Search Results - ming+hsu

1 Results

Sort By:

Microenvironment-informed combinatorial therapy for hepatocellular carcinoma

Unmet NeedSorafenib, a kinase inhibitor, has been the gold-standard treatment for most individuals with hepatocellular carcinoma (HCC); however, studies suggest survival after treatment remains less than 15% (Raoul et al. 2019). Additionally, side effects, including hand-foot skin reactions and diarrhea, are prevalent in almost half of patients being...

Published: 3/13/2025 | Inventor(s): Ming Hsu, Jih-Ru Hwu, Szu Wu, David Mold, Ru Chih Huang

Keywords(s): Cancers, Disease Indication, Liver Cancer, Therapeutic Matter, Therapeutics

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Hepatology, Clinical and Disease Specializations > Oncology > Liver Cancer, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Oncology